Nevro Corp (NYSE:NVRO)
$ 5.08 -0.26 (-4.87%) Market Cap: 189.40 Mil Enterprise Value: 157.99 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 44/100

Nevro Corp at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript

Feb 25, 2021 / 06:30PM GMT
Release Date Price: $167.14 (-2.21%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Well, everybody, welcome back. I'm still Joanne Wuensch, and this is still the Citi Healthcare Conference. And we are moving towards Nevro and very, very pleased to have Keith Grossman, Rod MacLeod and Julie Dewey, all here today, fresh off their fourth quarter earnings call. Everyone, welcome.

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Thanks, Joanne. Thanks for having us.

Questions & Answers

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

And I'm going to start big picture here, and then we'll whittle it down later, this morning. Keith, you've now been an Nevro for almost 2 years. And from an outsider, the company is oh so different. But I'll be curious what you're seeing and how it's evolved since you joined.

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Well, I think there have been certainly a lot of changes and a lot of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot